Pulmonary decline in a CF patient

M. Stahl (Heidelberg, Germany)

Source: Case Report 2010
Number: 2010

CME test or case report

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Stahl (Heidelberg, Germany). Pulmonary decline in a CF patient. Case Report 2010

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Pulmonary rehabiliatation for patient with intersitual lung disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019

Lung function decline in patients with bronchiectasis
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018

Maximal ventilatory pressure and pulmonary function in subjects with non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014

Pulmonary fibrosis in children
Source: Eur Respir J 2004; 24: Suppl. 48, 618s
Year: 2004

Changes in pulmonary function tests following antibiotics in infants with pulmonary exacerbation of cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013

Pulmonary hemodynamics and lung function in patients with COPD and DPLD
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Lung clearance index and exercise capacity among children with CF and non-CF bronchiectasis over a two year period
Source: International Congress 2015 – Clinical physiology: mechanisms of symptoms and exercise limitations in health and disease
Year: 2015

Pulmonary function testing in children's interstitial lung disease
Source: Eur Respir Rev, 29 (157) 200019; 10.1183/16000617.0019-2020
Year: 2020

Pulmonary function impairment in newly diagnosed pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 135s
Year: 2001

Effect of pulmonary hemodynamics on the prognosis of patients with emphysematous COPD after LVRS
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Tracking pulmonary exacerbations in preschool children using the lung clearance index
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016

The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced COPD
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Pulmonary rehabilitation in IPF
Source: International Congress 2018 – Interstitial lung disease: an interdisciplinary approach
Year: 2018

Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013

Effect of baseline FVC on lung function decline with nintedanib in patients with IPF
Source: International Congress 2015 – Treatment of IPF
Year: 2015

Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
Source: Eur Respir J 2012; 40: 61-66
Year: 2012

Pulmonary functional tests in patients with severe COPD after lung volume reduction surgery
Source: Eur Respir J 2002; 20: Suppl. 38, 606s
Year: 2002

Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015

Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021

Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014